American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Broadcom
AVGO
|
+$701M |
| 2 |
Mastercard
MA
|
+$306M |
| 3 |
Estee Lauder
EL
|
+$248M |
| 4 |
IQVIA
IQV
|
+$178M |
| 5 |
Arista Networks
ANET
|
+$163M |
Top Sells
| 1 |
Visa
V
|
+$560M |
| 2 |
Advanced Micro Devices
AMD
|
+$524M |
| 3 |
Apple
AAPL
|
+$439M |
| 4 |
NVIDIA
NVDA
|
+$318M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$261M |
Sector Composition
| 1 | Technology | 27.32% |
| 2 | Financials | 13.83% |
| 3 | Consumer Discretionary | 12.65% |
| 4 | Healthcare | 10.02% |
| 5 | Industrials | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLL
2751
DELISTED
Piedmont Lithium
PLL
| $109K | ﹤0.01% |
+12,525
| New | +$109K |
|
2752
Xerox
XRX
$463M
| $108K | ﹤0.01% |
12,771
-6,199
| -33% | -$52.3K |
|
2753
Sangamo Therapeutics
SGMO
$152M
| $107K | ﹤0.01% |
+105,337
| New | +$107K |
|
2754
Sera Prognostics
SERA
$118M
| $107K | ﹤0.01% |
13,183
-198
| -1% | -$1.61K |
|
2755
Alector
ALEC
$278M
| $107K | ﹤0.01% |
56,735
-7,103
| -11% | -$13.4K |
|
|
YRD
2756
Yiren Digital
YRD
$518M
| $107K | ﹤0.01% |
+22,334
| New | +$107K |
|
2757
Acrivon Therapeutics
ACRV
$47.8M
| $106K | ﹤0.01% |
17,588
+2,186
| +14% | +$13.2K |
|
2758
inTEST
INTT
$90.8M
| $105K | ﹤0.01% |
12,209
-1,372
| -10% | -$11.8K |
|
2759
Ultralife
ULBI
$114M
| $105K | ﹤0.01% |
14,057
-73
| -0.5% | -$544 |
|
2760
Synchronoss Technologies
SNCR
$66.9M
| $103K | ﹤0.01% |
+10,690
| New | +$103K |
|
|
CTV
2761
DELISTED
Innovid Corp.
CTV
| $100K | ﹤0.01% |
32,395
-428
| -1% | -$1.32K |
|
2762
Zentalis Pharmaceuticals
ZNTL
$107M
| $97.2K | ﹤0.01% |
32,084
+2,609
| +9% | +$7.91K |
|
2763
Tilly's
TLYS
$57.3M
| $95.5K | ﹤0.01% |
22,470
-361
| -2% | -$1.53K |
|
2764
Douglas Elliman
DOUG
$241M
| $94.5K | ﹤0.01% |
56,605
+33,011
| +140% | +$55.1K |
|
2765
Acumen Pharmaceuticals
ABOS
$80M
| $93.4K | ﹤0.01% |
54,278
-265
| -0.5% | -$456 |
|
2766
908 Devices
MASS
$202M
| $91K | ﹤0.01% |
41,343
-92
| -0.2% | -$202 |
|
2767
Sagimet Biosciences
SGMT
$220M
| $90.5K | ﹤0.01% |
+20,103
| New | +$90.5K |
|
2768
Zegna
ZGN
$2.22B
| $89.5K | ﹤0.01% |
10,840
| – | – |
|
2769
VistaGen Therapeutics
VTGN
$104M
| $88.5K | ﹤0.01% |
30,002
-195
| -0.6% | -$575 |
|
2770
PepGen
PEPG
$48.5M
| $85.7K | ﹤0.01% |
22,605
-175
| -0.8% | -$663 |
|
2771
KalVista Pharmaceuticals
KALV
$708M
| $85.3K | ﹤0.01% |
10,072
-24,651
| -71% | -$209K |
|
2772
Gaotu Techedu
GOTU
$901M
| $85.2K | ﹤0.01% |
38,912
| – | – |
|
2773
ESSA Pharma
EPIX
$9.6M
| $83K | ﹤0.01% |
46,373
-279
| -0.6% | -$499 |
|
2774
Inovio Pharmaceuticals
INO
$126M
| $80K | ﹤0.01% |
43,697
+2,873
| +7% | +$5.26K |
|
|
PGRE
2775
Paramount Group
PGRE
$1.57B
| $76.3K | ﹤0.01% |
15,443
-69,787
| -82% | -$345K |
|